ReNeuron Group (RENE) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Jul 2014 09:00 AM
RNS
Posting of Annual Report & Notice of AGM
24 Jun 2014 04:40 PM
RNS
Second Price Monitoring Extn
24 Jun 2014 04:35 PM
RNS
Price Monitoring Extension
20 Jun 2014 03:24 PM
RNS
Notification of Major Interest in Shares
20 Jun 2014 03:18 PM
RNS
Notification of Major Interest in Shares
18 Jun 2014 07:00 AM
RNS
Preliminary Results
03 Jun 2014 07:00 AM
RNS
Notification of Preliminary Results
14 May 2014 12:00 PM
RNS
Notification of Major Interest in Shares
08 May 2014 09:00 AM
RNS
Notification of Major Interest in Shares
07 May 2014 07:00 AM
RNS
Further Data from PISCES Trial
23 Apr 2014 07:00 AM
RNS
Corporate update
15 Apr 2014 07:00 AM
RNS
Signs Lease to New Facility in Wales
27 Mar 2014 07:00 AM
RNS
UK Clinical Trial Approvals
17 Mar 2014 11:00 AM
RNS
Block Listing Six Monthly Review
14 Mar 2014 12:45 PM
RNS
Support for Early Access to Medicines Scheme
11 Mar 2014 07:00 AM
RNS
Support for Retinal Stem Cell Therapy Candidate
21 Jan 2014 07:00 AM
RNS
Publication of Positive Pre-Clinical Data
27 Dec 2013 04:40 PM
RNS
Second Price Monitoring Extn
27 Dec 2013 04:35 PM
RNS
Price Monitoring Extension
10 Dec 2013 04:40 PM
RNS
Second Price Monitoring Extn
10 Dec 2013 04:35 PM
RNS
Price Monitoring Extension
02 Dec 2013 07:00 AM
RNS
Interim Results
19 Nov 2013 07:00 AM
RNS
Notification of Interim Results
17 Sep 2013 07:00 AM
RNS
Directors' Interest in Shares and Share Options
13 Sep 2013 11:04 AM
RNS
Results of 2013 Annual General Meeting
13 Sep 2013 07:00 AM
RNS
AGM Trading Update
29 Aug 2013 07:00 AM
RNS
Orphan Drug Designation
21 Aug 2013 07:00 AM
RNS
Director/PDMR Shareholding
21 Aug 2013 07:00 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
15 Aug 2013 07:00 AM
RNS
Posting of Annual Report & Notice of AGM
13 Aug 2013 07:00 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13 Aug 2013 07:00 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12 Aug 2013 07:00 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12 Aug 2013 07:00 AM
RNS
Director/PDMR Shareholding
12 Aug 2013 07:00 AM
RNS
Director/PDMR Shareholding
12 Aug 2013 07:00 AM
RNS
Director/PDMR Shareholding
12 Aug 2013 07:00 AM
RNS
Director/PDMR Shareholding
12 Aug 2013 07:00 AM
RNS
Director/PDMR Shareholding
12 Aug 2013 07:00 AM
RNS
Director/PDMR Shareholding
12 Aug 2013 07:00 AM
RNS
Director/PDMR Shareholding
12 Aug 2013 07:00 AM
RNS
Director/PDMR Shareholding
07 Aug 2013 11:03 AM
RNS
Result of General Meeting
01 Aug 2013 07:00 AM
RNS
Wins ?1.5 Million Grant
22 Jul 2013 07:01 AM
RNS
?33 Million Financing Package
22 Jul 2013 07:00 AM
RNS
Preliminary Results
18 Jul 2013 04:40 PM
RNS
Second Price Monitoring Extn
18 Jul 2013 04:35 PM
RNS
Price Monitoring Extension
01 Jul 2013 07:00 AM
RNS
Notification of Preliminary Results
01 Jul 2013 07:00 AM
RNS
Welcomes House of Lords Report
05 Jun 2013 04:40 PM
RNS
Second Price Monitoring Extn

ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug delivery platform with customizable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several exosome producer cell lines, its CustomEX platform can be optimized for specific tissue targets and payloads, leading to improvements in therapeutic outcome and a reduction in off-target effects. It offers a delivery mechanism for a variety of payloads such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. Through its conditionally immortalized induced pluripotent stem cell (iPSC) platform, it has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.

It listed on AIM in 2006 under the ticker RENE.

UK 100

Latest directors dealings